The Council of the European Union has adopted conclusions entitled 'The Future of the European Health Union: a Europe that cares, prepares and protects' in which it set out key areas of focus for EU health policy and encouraged the incoming European Commission to keep health as a priority. This includes as next step to consider the establishment of a voluntary, Member-State driven mechanism for evaluating and prioritising such needs and the EU-level coordination of public support to address the most pressing health-related unmet needs. The Council also calls on Member States and the Commission to strengthen action in priority areas by improving the EU’s implementation tools, including EU4Health, and developing new ones such as an EU health investment hub. Moreover, the Council adopted a recommendation setting out new measures on vaccine-preventable cancers, as part of Europe's Beating Cancer Plan. The recommendation aims to encourage the uptake and monitoring of vaccinations against human papillomaviruses (HPV) and Hepatitis B virus (HBV), both of which can cause cancer. It proposes measures to help Member States increase vaccination against non-preventable diseases. Finally, the Council held a policy debate on the incentives system in the pharmaceutical package, a Regulation and Directive proposed by the Commission in April 2023. Ministers discussed ways forward on the modulation of regulatory data protection periods, the market access incentive, and the unmet medical needs incentive. The Belgian presidency also updated ministers on the broader state of play of the package. The discussion included ministers expressing support for an unmet medical need (UMN) incentive, but feeling that the definition and criteria of this incentive should be further discussed, specifically regarding achieving legal certainty and objectivity in its application.